SCHEMBL7130885

SCHEMBL7130885

Cc1c(Br)cc(Br)c2c1C(=Cc1cc(O)cc(O)c1)C(=O)N2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 3/20 0.41
SIRT2 Q8IXJ6 2/20 0.41
SIRT3 Q9NTG7 2/20 0.41
LRRK2 Q5S007 3/20 0.39
RAF1 P04049 6/20 0.39
AURKA O14965 1/20 0.37
MAP1LC3B Q9GZQ8 3/20 0.36
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
EGFR P00533 1/20 0.36
NTRK1 P04629 1/20 0.36
ARAF P10398 1/20 0.36
PIM1 P11309 1/20 0.36
BRAF P15056 1/20 0.36
CSNK2A1 P68400 1/20 0.36
PIM3 Q86V86 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7133862 0.88 EEF2K (0.47) SIRT1SIRT2SIRT3LRRK2RAF1
SCHEMBL7133993 0.88 METAP1 (0.50) SIRT1SIRT2SIRT3LRRK2PSEN1
SCHEMBL7134037 0.88 MAP1LC3B (0.45) SIRT1SIRT2SIRT3LRRK2RAF1
SCHEMBL7131324 0.86 MAP1LC3B (0.52) SIRT1SIRT2SIRT3LRRK2RAF1
SCHEMBL7136631 0.84 LRRK2 (0.43) LRRK2EGFRMEN1PLK4USP2
SCHEMBL7133805 0.84 SIRT1 (0.36) SIRT1SIRT2SIRT3LRRK2RAF1
SCHEMBL7132917 0.84 EGFR (0.51) SIRT1SIRT2SIRT3LRRK2RAF1
SCHEMBL7138236 0.84 EGFR (0.51) EGFRMEN1CYP1A2CYP2C9KMT2A
SCHEMBL7133880 0.83 LRRK2 (0.48) SIRT1SIRT2SIRT3LRRK2RAF1
SCHEMBL8193593 0.83 PLK4 (0.51) LRRK2MEN1PLK4MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 US disclosed
US-6133305-A PREVENTION AND TREATMENT OF PROTEIN KINASE RELATED DISORDERS SUCH AS CANCER SUGEN, INC. (US) 2000-10-17 US disclosed